In fact, many experimental and clinical studies confirmed that GLO1 inducers and/or dicarbonyl scavengers represent potential effective agents to reverse or limit diabetes-related complications [70,91,92,93,94]. This evidence concerns the gene GLO1 and diabetes mellitus.